StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued to investors on Thursday. The firm set a “buy” rating on the stock.
Mannatech Stock Performance
Shares of NASDAQ MTEX opened at $8.42 on Thursday. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $15.87 million, a price-to-earnings ratio of -10.39 and a beta of 1.06. Mannatech has a 52-week low of $6.75 and a 52-week high of $16.49. The stock’s fifty day simple moving average is $10.92 and its 200 day simple moving average is $10.10.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings data on Wednesday, March 26th. The company reported $1.20 earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The firm had revenue of $29.01 million during the quarter.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- How to start investing in penny stocks
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- How to Use the MarketBeat Stock Screener
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Read Stock Charts for Beginners
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
